INFORMATION FOR
News
A novel mechanism in platelets, triggered by unfolded protein response or UPR, may reduce the risk of potentially fatal blood clots in people with type II diabetes.
The AHA Career Development Award helps health care and academic professionals launch high-impact careers.
Researchers investigated the link between the common artificial sweetener erythritol and cardiovascular risk.
Kathleen Martin and John Hwa show that it's possible to work successfully with a romantic partner.
Arya Mani, MD, outlined three recent discoveries from his lab.
Aged bone marrow promotes the expansion of arterial smooth muscle cells and exacerbates the build-up of fatty deposits in artery walls, a new Yale study found.
Yale researchers have identified a potential target for the development of antihypertensive drugs.
Óscar Bártulos-Encinas, PhD, reflects on his transition from the Yale Cardiovascular Research Center to industry.
Stefania Nicoli, PhD, associate professor at the Yale School of Medicine (YSM) Section of Cardiovascular Medicine and the Department of Genetics, has received the Established Investigator Award from the American Heart Association (AHA).
Jui Dave, PhD, an associate research scientist in the Greif Lab, was awarded a Career Development Award from the American Heart Association.
Inamul Kabir, PhD, was selected for a Career Development Award (2022-2025) from the American Heart Association.
Research led by Muhammad Riaz, PhD, Jinkyu Park, PhD, and Lorenzo Sewanan, MD, PhD, provides a mechanism to identify abnormalities linked with hypertrophic cardiomyopathy.
At the Yale School of Medicine, Fadi G. Akar, PhD, aims to broaden the framework through which sudden cardiac death is studied.
After 13 years at Yale, Hyung Chun, MD, is joining Foresite Capital.
Research from the Yale School of Medicine indicates that a protein kinase that is a master regulator of cell metabolism is critical to preventing atrial fibrillation.
Kathleen Martin, PhD, will give the Alexander W. Clowes Distinguished Lecture at the 2022 Vascular Research Initiatives Conference in May.
A renewed interest in intravenous ascorbic acid, also known as vitamin C, could improve long-term success outcomes for patients undergoing solid-organ transplant.
Dr. Pengchun Yu is an alumnus of the Yale Cardiovascular Research Center (CVRC).
A genetic disorder in PRDM6 causes a common congenital heart defect in premature infants — suggesting a potential target for the treatment of congenital heart diseases.
Stefania Nicoli, PhD, has been selected as the recipient of the 2022 Judah Folkman Award in Vascular Biology. This award recognizes outstanding contributions from vascular biologists.